Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients.
暂无分享,去创建一个
R. Maserati | E. Seminari | F. Castelli | P. Viale | C. Torti | M. Regazzi | P. Villani
[1] R. Maserati,et al. High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma. , 1999, Therapeutic drug monitoring.
[2] R. Maserati,et al. High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease. , 1999, AIDS.
[3] D. Back,et al. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. , 2003, British journal of clinical pharmacology.
[4] D. Back,et al. Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV‐infected patients , 1997, AIDS.
[5] P. Anderson,et al. L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase , 1995, Antimicrobial agents and chemotherapy.